Model Validation for Antiepileptogenic and Resistant Epilepsy Therapies

The summary for the Model Validation for Antiepileptogenic and Resistant Epilepsy Therapies grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Model Validation for Antiepileptogenic and Resistant Epilepsy Therapies: The NINDS invites applications to validate animal models of pharmacoresistant epilepsy or intervention in the epileptogenic processes leading to chronic disease. The goal of this grant program is to validate proposed models of pharmacoresistant epilepsy and/or antiepileptogenic models for use in drug discovery. It will establish baseline data and introduce new methods for evaluating the therapeutic potential of novel compounds for the treatment of epilepsy.

Federal Grant Title:	Model Validation for Antiepileptogenic and Resistant Epilepsy Therapies
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-NS-04-002
Type of Funding:	Grant
CFDA Numbers:	93.853
CFDA Descriptions:	Extramural Research Programs in the Neurosciences and Neurological Disorders
Current Application Deadline:	No deadline provided
Original Application Deadline:	Nov 21, 2003
Posted Date:	Aug 22, 2003
Creation Date:	Dec 21, 2003
Archive Date:	Dec 21, 2003
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [email protected] NIH OER Webmaster
Similar Government Grants: • ADRD Risk and Disease Following Nervous System Exposures at Biological Interfaces with the...; • Optimization of Genome Editing Therapeutics for Alzheimer's Disease-Related Dementias (ADR...; • Materials to Enhance Training in Experimental Rigor (METER) (UE5 - Clinical Trial Not Allo...; • Interaction Between Environmental Factors and Lewy Body Dementia (R01 - Clinical Trial Not...; • NINDS Alzheimers Disease-Related Dementias (ADRD) Advanced Postdoctoral Career Transition ...; • NINDS Cooperative Small Business Awards In Translational Research (SBIR/U44); • NINDS Institutional Center Core Grants to Support Neuroscience Research; • Career Development Award to Promote Diversity in Neuroscience Research
More Grants from the National Institutes of Health: • Research Centers in Minority Institutions (RCMI) (U54 - Clinical Trial Optional); • Urology Centers Program Interactions Core (U24 Clinical Trial Not Allowed); • Coordinating Center to Support Consortium for Neuroscience Alzheimers Disease (AD) and AD-...; • Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials o...; • Administrative Supplements to Promote Diversity in Research and Development Small Business...